Mohamed Oukka

Active 1996–2024

56
Papers
37,224
Citations
53
h-index
56
i10-index

Citations

Citations per year for Mohamed Oukka1960: 1 citations1998: 12 citations1999: 13 citations2000: 32 citations2001: 27 citations2002: 41 citations2003: 21 citations2004: 12 citations2005: 32 citations2006: 104 citations2007: 383 citations2008: 817 citations2009: 1,063 citations2010: 1,045 citations2011: 951 citations2012: 769 citations2013: 737 citations2014: 657 citations2015: 608 citations2016: 533 citations2017: 525 citations2018: 463 citations2019: 1,211 citations2020: 1,260 citations2021: 1,126 citations2022: 851 citations2023: 617 citations2024: 800 citations2025: 376 citations2026: 9 citations1961–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,263 citing papers, 31.2% of this breakdownChina: 1,912 citing papers, 11.3% of this breakdownGermany: 1,105 citing papers, 6.6% of this breakdownUnited Kingdom: 1,000 citing papers, 5.9% of this breakdownJapan: 798 citing papers, 4.7% of this breakdownItaly: 581 citing papers, 3.4% of this breakdownFrance: 571 citing papers, 3.4% of this breakdownCanada: 494 citing papers, 2.9% of this breakdownAustralia: 424 citing papers, 2.5% of this breakdownSwitzerland: 351 citing papers, 2.1% of this breakdownNetherlands: 350 citing papers, 2.1% of this breakdownSpain: 286 citing papers, 1.7% of this breakdown
0%31.2%Other 22.2%

Fields

  • Immunology and Microbiology43.5%
  • Medicine30.3%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Neuroscience4%
  • Environmental Science0.9%
  • Nursing0.8%
  • Other2%

Topics

  • Immune Cell Function and Interaction10.2%
  • T-cell and B-cell Immunology9.6%
  • Psoriasis: Treatment and Pathogenesis4.9%
  • Immunotherapy and Immune Responses4.8%
  • IL-33, ST2, and ILC Pathways3%
  • Immune Response and Inflammation2.2%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

    Authors: , , , , , , , - Nature 2006 cited by 6,993

  2. IL-17 and Th17 Cells

    Authors: , , , - Annual Review of Immunology 2009 cited by 4,785

  3. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 2007 cited by 2,384

  4. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor

    Authors: , , , , , , , , - Nature 2008 cited by 1,842

  5. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 1,319

  6. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

    Authors: , , , , , , - The Journal of Experimental Medicine 2007 cited by 1,850

  7. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2016 cited by 387

  8. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells

    Authors: , , , , , , , , , , , , - Nature Immunology 2008 cited by 1,095

  9. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells

    Authors: , , , , , , , - Nature 2007 cited by 1,840

  10. Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys

    Authors: , , , , , , , , - The Journal of Immunology 2008 cited by 793

  11. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 535

  12. IL-9 induces differentiation of T H 17 cells and enhances function of FoxP3 + natural regulatory T cells

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 500

  13. IL-21 and TGF-β are required for differentiation of human TH17 cells

    Authors: , , , , , , , - Nature 2008 cited by 907

  14. IL-23 stabilizes an effector Treg cell program in the tumor microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2024 cited by 56

  15. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism

    Authors: , , , - Mucosal Immunology 2013 cited by 203

  16. TH-17 cells in the circle of immunity and autoimmunity

    Authors: , , - Nature Immunology 2007 cited by 1,513

  17. A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells

    Authors: , , , , , , , , - Nature Immunology 2007 cited by 802

  18. Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-β-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression

    Authors: , , , , , , - The Journal of Immunology 2008 cited by 521

  19. Induction and effector functions of TH17 cells

    Authors: , , , - Nature 2008 cited by 1,212

  20. Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells

    Authors: , , , , , , , , - The Journal of Immunology 2009 cited by 363

  21. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation

    Authors: , , , , , , , , , , , - Nature Medicine 2007 cited by 816

  22. T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt

    Authors: , , , , , , , , - Nature Immunology 2010 cited by 370

  23. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3 + regulatory T cells

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 506

  24. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 481